Dysport DC
Featured Company
Center for Laser Surgery
a top rated center that has achieved international recognition as a pioneer in Cosmetic Laser Surgery. Focus includes cosmetic laser surgery, dermatology and vein care.
What is Reloxin
Reloxin is a non invasive injectable cosmetic procedure that is new to the United States. It is a neuromuscular blocking toxin (Botulinum Toxin Type A) that paralyzes facial muscles and erases fines and wrinkles. Reloxin is recommended for patients from ages 35 to 65.
The Procedure
During an office visit a cosmetic provider injects Reloxin directly into the wrinkle, paralyzing the surrounding muscle, and causing the wrinkle to disappear. The patient can go home immediately after the procedure. Results are visible in as little as one day and last anywhere from 6months to 1 year. The cost of the procedure is approximately $300.00.
Side Effects of Reloxin
Side effects include swelling, redness and bruising at the injection site. Headaches may also occur. There is also a slight risk that the body will develop antibodies to Reloxin, causing it to no longer work.
The History of Reloxin
Reloxin was first used in the U.K. in 1991 to treat muscle spasms and movement disorders. It was soon discovered that it could alleviate fine lines and wrinkles as well. It was approved for cosmetic use in countries outside of the U. S. in 2001. In March of 2006 Ipsen, the international pharmaceutical company and manufacturer of the product, joined forces with U.S. pharmaceutical company, Medicis to develop and market Reloxin in the U.S., Canada, and Japan. Meanwhile Ipsen gained approval to market the product for aesthetic use in 21 countries outside of the U.S in 2007. In March of 2008 Medicis and Ipsen submitted a Biologics License Application (B.L.A.) for Reloxin to the Food and Drug Administration for approval. During the approval process, Reloxin’s safety was studied in clinical trials of 376 patients.
Reloxin Today
In April 2006 the F.D.A. approved Reloxin for aesthetic use as well as for treatment of Cervical Dystonia in the United States. One of the conditions of approval was that the product be marketed under its original name, Dysport. Because of the pre-approval publicity the product received as Reloxin, the two names are often used interchangeably. Today Dysport is marketed and sold as an aesthetic treatment in 38 countries, including the United States.